Aridis Pharmaceuticals Inc. (ARDS) Social Stream
ARIDIS PHARMACEUTICALS INC (ARDS) Price Targets From Analysts
Use the tables below to see what analysts covering ARIDIS PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-02 | 4 | $22 | $13 | $18 | $0.31 | 5706.45% |
| 2021-11-11 | 4 | $19 | $10 | $15 | $0.31 | 4738.71% |
| 2022-04-05 | 2 | $19 | $10 | $14 | $0.31 | 4416.13% |
| 2022-04-08 | 2 | $19 | $5 | $11.333 | $0.31 | 3555.81% |
| 2022-06-07 | 3 | $19 | $5 | $9.666 | $0.31 | 3018.06% |
| 2022-08-22 | 3 | $19 | $5 | $9.666 | $0.31 | 3018.06% |
| 2022-11-23 | 3 | $19 | $2 | $10.5 | $0.31 | 3287.1% |
| 2023-01-26 | 1 | $10 | $10 | $10 | $0.31 | 3125.81% |
| 2023-03-13 | 2 | $10 | $2 | $6 | $0.31 | 1835.48% |
The Trend in the Analyst Price Target
Over the past 34 months, ARDS's average price target has gone down $12.6.
ARDS reports an average of 870.4% for its upside potential over the past 30 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-17 | 3 | 19 | 5 | 9.666 | 1.830 | 428.2% |
| 2022-08-22 | 3 | 19 | 5 | 9.666 | 1.500 | 544.4% |
| 2022-08-22 | 3 | 19 | 5 | 12.000 | 1.500 | 700% |
| 2023-01-26 | 3 | 10 | 2 | 6.000 | 0.800 | 650% |
| 2023-03-13 | 2 | 10 | 2 | 6.000 | 0.545 | 1000.92% |
ARDS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
ARDS's average broker recommendation rating worsened by 0.67 over the prior 43 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ARIDIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1193.98% of them.
- ARIDIS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 88.58% of all US stocks.
- ARDS has a lower variance in analysts' estimates than -838.14% of stocks in the micro market cap category.
- ARDS has a greater average analyst price target than 251.55% of Healthcare stocks.
Stocks similar to ARIDIS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCNX, XCUR, and ASLN.
View All Top Stocks by Price Target
What is the outlook for ARDS? Use POWR Ratings for clearer insight into price direction.